Paliperidone Pregnancy and Breastfeeding Warnings

Paliperidone is also known as: Invega, Invega Sustenna

Paliperidone Pregnancy Warnings

Patients should be advised to notify their physician if they become pregnant or intend to become pregnant during treatment with paliperidone. The extrapyramidal symptoms are usually self-limited. It is not known whether paliperidone, when taken near the end of pregnancy, will lead to similar neonatal signs and symptoms.

Paliperidone has been assigned to pregnancy category C by the FDA. Animal studies have revealed increased pre and post implantation loss, a slightly decreased number of live embryos, and decreases in serum testosterone, sperm motility and sperm concentration. There are no controlled data in human pregnancy. Neonates exposed to antipsychotic drugs during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery. There have been reports of agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress and feeding disorder in these neonates. These complications have varied in severity; while in some cases symptoms have been self-limited, in other cases neonates have required intensive care unit support and prolonged hospitalization. Paliperidone is only recommended for use during pregnancy when there are no and benefit outweighs risk.

Paliperidone Breastfeeding Warnings

Paliperidone is excreted into human milk. The manufacturer recommends that patients should be advised not to breast-feed an infant if they are taking paliperidone.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.